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ABSTRACT
Background/Aims: Studies in adult population have suggested that leptin might play a role in
inducing obesity related hypertension mediated by the sympathetic nervous system. This associ-
ation has not been established for adolescents. Our study is designed to explore the relationship
between leptin and norepinephrine levels in pediatric patients and to identify any contributors
to hypertension for this population. 
Methods: Thirty-nine obese adolescents, divided into four groups by gender and hypertension
status were included in the study. Leptin and norepinephrine levels were measured during oral
glucose tolerance tests (OGTT) to optimize hormonal secretion. T tests were used to compare
baseline levels of glucose, insulin, leptin and norepinephrine at 0 hour point of OGTT between
the hypertensive and normotensive patients for both genders. Analysis of covariance (ANCOVA)
was used for comparison of subsequent levels between the hypertensive and normotensive
groups for in both genders, with the corresponding baseline level as the covariance. Models with
and without BMI adjustment were created and their results were found to be consistent.
Correlation between leptin and norepinephrine was examined at each time point and through
analysis of area under the curve (AUC).
Results: Contrary to the previous findings obtained in adult patients, our results did not show
any direct relationships between levels of leptin and norepinephrine. A slight decrease in norep-
inephrine level at 1 hour in the normotensive male group and a significant increase in leptin level
at 1 hour in the hypertensive female group was observed. 
Conclusion: Our preliminary data suggest that norepinephrine and leptin levels at 0 and 1 hour
during routine OGTT, for males and females, respectively, may help identify a subgroup of obese
adolescents who have higher risk for hypertension and cardiovascular complications. 
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useINTRODUCTION
It has been proposed that leptin, the most
abundant adipose-specific protein, plays a
central role in inducing hypertension. Animal
studies suggest that there is a dual interaction
of leptin and the sympathetic nervous system.
It is hypothesized that leptin, acting within
the hypothalamus, causes activation of cen-
tral sympathetic outflow and stimulates adre-
nal medullary release of epinephrine, and
conversely, the sympathetic nervous system
inhibits leptin release from white adipose tis-
sue.
1-6 A few studies in adults
7-8 provided some
preliminary evidence which also suggested
that hyperlepitinemia associated with obesity
causes sympathetic over-activity and hyper-
tension. One study found that glucose load-
ing increased circulating leptin concentrations
in obese women and demonstrated the exis-
tence of an association between leptin and
norepinephrine changes during oral glucose
tolerance test (OGTT) in both normotensive
and hypertensive obese women.
8
An increment in leptin levels is observed as
body fat mass increases. Also, the serum leptin
level can change independently of fat mass.
Leptin levels decrease during fasting and
increase after meals.
9 Both insulin and glucose
have been implicated in modulating serum lep-
tin levels.
10-11 In an attempt to assess the maxi-
mum effect of leptin on the sympathetic nerv-
ous system, we measured the hormonal levels
(leptin and norepinephrine) during OGTT. 
The goal of this study was to assess the
relationship of leptin and norepinepherine in
normotensive and hypertensive obese adoles-
cents during an oral glucose challenge test. 
SUBJECTS AND METHODS
This research was conducted in the
Clinical Research Center at the New York
University (approved by the Internal Review
Board of the School of Medicine at NYU). A
total of 39 obese adolescents were divided
into 4 groups: Group 1: 13 normotensive
females; Group 2: 8 hypertensive females;
Group 3: 8 normotensive males; and Group
4: 10 hypertensive males. The only inclusion
criterion was obesity, regardless of gender,
ethnicity, or status of hypertension.
Exclusion criteria included any underlying
diseases that could have caused hyperten-
sion, type 2 diabetes mellitus, or conditions
that were being treated with medications.
Obesity was defined as a body mass
index (BMI) equal to or greater than 95th per-
centile for age and sex. Hypertension is gen-
erally defined as either a systolic or a diastolic
blood pressure that is equal to or greater than
the 90th percentile for age, gender, and
height.
12 In our hypertensive groups, both
systolic and diastolic blood pressures were
above the 90th percentile. All subjects under-
went a thorough clinical screening, which
included history and physical examination. A
comprehensive laboratory assessment includ-
ed measurement of thyroid hormone, elec-
trolytes, liver functions and renal function
tests. We also measured fasting lipid levels. 
A 3-hour oral glucose tolerance test was
performed on all subjects, which started bet-
ween 8 to 8.30 am. The subjects had been
instructed to fast for at least 10 hours prior to
the test. Glucose, insulin, leptin and norepi-
nephrine levels were measured at 0, 1, 2, and
3 hours, respectively. Norepinephrine, leptin
and all related tests were analyzed by an in-
dependent laboratory (Quest Diagnostics).
Norepinephrine was measured by high per-
formance liquid chromatography with both
intra-assay and inter-assay variation of less
than 10%. Leptin was determined by radioim-
munoassay with intra-assay and inter-assay
variation of 4.2% and 9.8%, respectively.
Statistical Analysis
Areas under the curve (AUC) for leptin,
norepinephrine, insulin, and glucose levels
were calculated by the trapezoidal rule.
Relationships among variables as well as their
AUCs were evaluated using the Pearson cor-
relation coefficient and multiple linear regres-
sion analysis. Mean levels of leptin, norepi-
nephrine, insulin, and glucose at baseline (0
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hypertensive group and normotensive group
using t tests. Mean levels of leptin, norepi-
nephrine, insulin, and glucose at 1, 2, and 3
hours were compared using analysis of
covariance (ANCOVA), between the hyper-
tensive group and normotensive group for
both sexes, where the corresponding base-
line levels are treated as covariance. Models
with and without BMI adjustments were com-
pared. Data were expressed as mean + SE.
Two-tailed values of p < 0.05 were consid-
ered statistically significant. These analyses
were performed using the SAS statistical
package (SAS Institute, Cary, NC).
RESULTS
Neither multiple linear regressions nor
correlation analyses showed any direct rela-
tionship between leptin and norepinephrine
in any of the groups. When t tests were used
to compare baseline levels of leptin, norepi-
nephrine, insulin, and glucose between the
hypertensive patients and the normotensive
patients, no significant differences were
found among the groups in either gender. 
In ANCOVA comparisons of subsequent
levels of leptin, norepinephrine, insulin, and
glucose, there was a statistically significant
difference between the two male groups in
norepinephrine levels at 1 hour during
OGTT, the hypertensive male group having a
higher mean norepinephrine level compared
to the normotensive group (Δ=71.2, and
p=0.002 with adjustment for BMI; and Δ=74.7,
and p=0.001 without adjustment for BMI). 
The only statistically significant differ-
ence between the two female groups was in
the leptin levels at 1 hour, where the hyper-
tensive female group had a higher mean
level compared to the normotensive group
(Δ=135.0, and p=0.015 with adjustment for
BMI; and Δ=130.9, and p=0.016 without
adjustment for BMI). 
It is also noted that although the insulin
level appears much higher in the female
hypertensive group than in the female nor-
motensive group, the difference is not statis-
tically significant due to large standard errors.
In our male groups, both leptin, and norepi-
nephrine levels appear much higher in the
hypertensive group than in the normotensive
group, but the differences again fail to attain
statistical significance, due to the same rea-
son (large standard errors), except for the
norepinephrine level at 1 hour. 
Patient characteristics and leptin, norepi-
nephrine, insulin, and glucose levels during
OGTT are summarized in Table 1 and 2 and
Figures 1-a to 1-d. 
DISCUSSION
Leptin secretion is correlated with BMI
and increases during puberty. There is a sex-
ual dimorphism with higher levels in
females.
13 In addition, serum leptin level can
change independently of the fat mass. Leptin
levels decrease during fasting and increase
after meals or glucose loading.
9-11,14-16
It is postulated that there is a dual inter-
action of leptin and the sympathetic nervous
system. Increasing leptin levels, usually
associated with anabolic status such as
increased BMI and meals, can suppress sati-
ety associated with weight-reduction and
stimulate sympathetic activity which could
induce hypertension. Conversely, increased
sympathetic nervous system activity sup-
presses leptin secretion. However, obesity
may alter this balance. Based on studies of
obese mice, Mark et al
6 introduced a novel
concept of selective leptin resistance which
suggests that hyperlepitinemia could con-
tribute to increases in sympathetic activity
and increased blood pressure in obese
states, where there is a resistance to the
metabolic (satiety and weight-reducing)
actions of leptin. There are not many clinical
studies that were designed to establish a
direct relationship between leptin and nor-
epinephrine levels in obesity status. A study
by Corica et al
8 demonstrated a positive
association between leptin and norepineph-
rine changes during OGTT in both nor-
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The authors of that study hypothesized that
this association may reflect a lack of leptin
suppression by catecholamines or a direct
leptin-induced sympathoactivation  Recenly,
another study by Flanagan et al, “Gender
differences in the relationship between lep-
tin, insulin resistance and the autonomic
nervous system”,
17 which included 130
young adults, suggested that the gender dif-
ference and leptin in women is associated
with sympathetic nervous system activity.
In the present study, the results did not
show any significant correlation between
leptin and norepinephrine levels in hyper-
tensive or normotensive groups in either
Relationship Between Leptin and Norepinephrine Levels During OGTT
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Table 1: General characteristics of the study groups (Mean±SE)
Normotensive Hypertensive Normotensive Hypertensive
Female Female Male Male
Number of Patients 13 8 8 8
Age (year) 15.6±1.7 15.0±1.9 15.5±2.2 14.7±1.8
BMI (kg/m2) 38.2±6.4 35.9±6.8 37.0±4.3 35.8±3.8
SBP (mmHg) 115±6 128±7 120±4 131±7
DBP (mmHg) 65±6 80±3 67±5 79±2
Cholesterol (mg/dL) 158±39 158±26 142±27 166±39
HDL (mg/dL) 39±8 41±11 33±5 36±5
LDL (mg/dL) 103±38 98±18 81±25 105±28
TG (mg/dL) 83±45 95±47 106±56 122±56
BMI: body mass index
SBP: systolic blood pressure
DBP: diastolic blood pressure
TG: triglyceride
Table 2: Biochemical data on Glucose, Insulin, Norepinephrine and Leptin levels during OGTT of the study groups
(Mean±SE)
Normotensive Hypertensive Normotensive Hypertensive
Hour Female Female Male Male
Number of Patients 13 8 8 10
Glucose (mg/dL) 0 81.7±6.7 81.4±9.9 87.5±11.7 83.7±5.6
1 122.3±23.6 134.3±24.8 141.4±44.9 134.5±14.1
2 118.2±26.5 121.9±22.4 117.9±22.3 122.1±10.2
3 78.8±16.0 89.9±13.6 86.3±21.2 87.7±25.9
Insulin (μIU/mL) 0 18.9±5.5 25.6±18.1 26.7±10.3 25.4±9.2
1 116.5±70.2 209.0±144.5 123.0±71.2 176.0±101.2
2 100.4±65.3 193.1±217.1 116.3±81.7 155.6±100.5
3 45.6±31.9 79.4±86.7 62.4±71.4 89.4±78.5
Norepinepherine (pg/mL) 0 192.9±84.9 215.5±85.6 271.9±74.2 285.1±132.3
1 247.6±128.8 248.4±61.4 207.4±46.5 289.8±89.4
2 224.9±118.0 188.4±48.7 245.4±57.9 281.3±106.2
3 242.3±103.3 198.0±39.3 235.5±52.9 301.1±118.4
Leptin (pg/mL) 0 680.2±338.1 596.7±223.2 311.1±96.9 380.1±172.2
1 642.0±371.9 687.6±222.9 355.9±101.2 380.1±188.6
2 674.2±360.0 645.2±221.3 355.6±70.7 435.4±368.4
3 709.5±346.3 644.2±156.9 320.9±105.5 399.8±287.2gender. However, statistical powers of the
tests, which were generally below 0.90, were
not sufficient to exclude possible type II
errors, due to the small sample size. In the
male groups, both leptin and norepinephrine
levels were much higher in the hypertensive
group. Although the difference did not reach
statistical significance of p=0.05 at most time
points, we cannot exclude the possibility that
this finding could be due to type II errors.
Interestingly, the only statistically significant
difference between the norepinephrine lev-
els of the two male groups at 1 hour is
caused mainly by a decrease of norepineph-
rine levels at 1 hour in the normotensive
group (see Table 2 and Fig. 1-c) instead of an
increase in the hypertensive group. 
The female groups had higher leptin lev-
els than the two male groups, which is an
indication of sexual dimorphism. There was a
significant increase in leptin levels at 1 hour
in the hypertensive group. This may suggest
that sympathetic over-activity manifested by
hypertension may be related to hyperleptine-
mia, which is consistent with the conclusion
of a recent study by Flanagan, et al.
17
Our study represents the first attempt to
explore the relationship between leptin, nor-
epinephrine, insulin and glucose levels in
obese adolescents. Although no significant
relationship between these hormones was
observed in this study, our data is still inter-
esting because it reveals different patterns in
norepinephrine levels at 1 hour during
OGTT for the male groups (a dip for the
normotensive group) and in leptin levels at
1 hour during OGTT for the females (an
increase for the hypertensive group). These
differences imply that norepinephrine and
leptin at 0 and 1 hour during routine OGTT
for males and females, respectively, may
help identify a subgroup of obese adoles-
cents who have higher risks for hyperten-
sion and cardiovascular complications. 
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Figure 1c Norepinephrine: Male
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Figure 1b Leptin: Female
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Figure 1: Norepinephrine and Leptin levels during OGTT in the females and males with or without hypertension We realize the limitations of this study:
a small sample size, lack of a lean control
group, and the method of collection and
measurement of norepinephrine levels.
Further studies with groups including lean
controls, measurement of 24 hour urinary
norepinephrine, and larger sample sizes
are warranted to confirm our findings.
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